choosing a pi3k inhibitor in relapsed follicular lymphoma
Published 5 years ago • 66 plays • Length 3:13Download video MP4
Download video MP3
Similar videos
-
2:02
pi3k inhibition for r/r follicular lymphoma
-
3:40
pi3k inhibitors for relapsed/refractory fl
-
3:47
pi3k inhibitors in management of r/r follicular lymphoma
-
4:27
treating r/r follicular lymphoma with pi3k inhibitors
-
4:53
follicular lymphoma: selecting therapy at relapse
-
3:37
pi3-kinase inhibitors for follicular lymphoma
-
3:41
treatment options for relapsed follicular lymphoma
-
6:15
therapy for relapsed follicular lymphoma
-
5:33
managing toxicities of pi3k inhibitors in fl
-
8:32
pi3k-targeted therapy for r/r follicular lymphoma
-
3:15
pi3k-targeted therapy for follicular lymphoma
-
22:46
follicular lymphoma debate: chemotherapy no longer has a major role in the treatment
-
3:25
staging relapsed follicular lymphoma
-
6:50
treatment after progression in follicular lymphoma
-
2:18
copanlisib in the treatment of relapsed follicular lymphoma - video abstract [id 201024]
-
30:25
exploring novel approaches with pi3k inhibitors in r/r follicular and marginal zone lymphoma
-
4:21
deciding on therapy for follicular lymphoma
-
4:37
prognosis and treatment of follicular lymphoma
-
4:50
follicular lymphoma: rationale for selecting copanlisib